Compounds > razoxane
Page last updated: 2024-08-23

razoxane and Disease Models, Animal

razoxane has been researched along with Disease Models, Animal in 18 studies

Research

Studies (18)

TimeframeStudies, this research(%)All Research%
pre-19904 (22.22)18.7374
1990's2 (11.11)18.2507
2000's7 (38.89)29.6817
2010's5 (27.78)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Adamcová, M; Aupperle, H; Geršl, V; Mazurová, Y; Popelová, O; Potáčová, A; Štěrba, M1
Chen, Y; Li, K; Ng, PC; Pong, NH; Shen, J; Sung, RY; Xiang, P; Zhou, L1
Jensen, PB; Langer, SW; Sehested, M; Thougaard, AV1
Filipský, T; Holečková, M; Hrdina, R; Macáková, K; Mladěnka, P; Palicka, V; Semecký, V; Vávrová, J; Zatloukalová, L1
Boudíková, A; Dabrowská, L; Geršl, V; Kolář, F; Mandíková, P; Mikšík, I; Mráz, J; Neckář, J; Popelová, O; Stěrba, M1
Hasinoff, BB1
Freireich, EJ; Jendiroba, D; Keyhani, A; Liu, B; Pagliaro, L; Pearlman, M; Travis, E1
de Vries, EG; Perik, PJ; van den Berg, MP; van Veldhuisen, DJ1
Adamcová, M; Gersl, V; Hrdina, R; Kaplanová, J; Klimtová, I; Mazurová, Y; Simůnek, T; Sterba, M1
Ding, J; Lu, DY; Xu, B1
Adamcová, M; Gersl, V; Holecková, M; Hrdina, R; Kaplanová, J; Klimtová, I; Simůnek, T; Sterba, M1
Adamcová, M; Čajnáková, H; Gersl, V; Hrbatová, L; Ponka, P; Popelová, O; Potáčová, A; Šimůnek, T; Sterba, M1
Carter, WH; Stablein, DM; Wampler, GL1
Bartoli Klugmann, F; Decorti, G; Klugmann, S1
Ferrans, VJ; Herman, EH1
Casazza, AM; Di Marco, A; Giuliani, F; Savi, G1
Peters, LJ1
Bale, G; Chesney, TM; Noah, PW; Rosenberg, EW; Skinner, RB; Xu, B1

Reviews

1 review(s) available for razoxane and Disease Models, Animal

ArticleYear
Preclinical animal models of cardiac protection from anthracycline-induced cardiotoxicity.
    Seminars in oncology, 1998, Volume: 25, Issue:4 Suppl 10

    Topics: Animals; Anthracyclines; Antineoplastic Agents; Cardiomyopathies; Cardiovascular Agents; Disease Models, Animal; Dogs; Heart; Mice; Rabbits; Rats; Razoxane; Swine

1998

Other Studies

17 other study(ies) available for razoxane and Disease Models, Animal

ArticleYear
Cardiac remodeling and MMPs on the model of chronic daunorubicin-induced cardiomyopathy in rabbits.
    Physiological research, 2010, Volume: 59, Issue:5

    Topics: Animals; Antibiotics, Antineoplastic; Cardiomyopathies; Cardiovascular Agents; Chronic Disease; Collagen; Daunorubicin; Disease Models, Animal; Drug Interactions; Fibrosis; Hydroxyproline; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Myocardium; Rabbits; Razoxane; Ventricular Remodeling

2010
Cardioprotective effect of dexrazoxane in a rat model of myocardial infarction: anti-apoptosis and promoting angiogenesis.
    International journal of cardiology, 2011, Oct-20, Volume: 152, Issue:2

    Topics: Animals; Apoptosis; bcl-2-Associated X Protein; Blood Cell Count; Bone Marrow Cells; Capillaries; Cardiotonic Agents; Disease Models, Animal; Down-Regulation; Echocardiography; Endothelial Cells; Male; Myocardial Infarction; Myocardium; Neovascularization, Physiologic; Rats; Rats, Sprague-Dawley; Razoxane; Stem Cells; Stroke Volume

2011
Treatment of experimental extravasation of amrubicin, liposomal doxorubicin, and mitoxantrone with dexrazoxane.
    Cancer chemotherapy and pharmacology, 2012, Volume: 69, Issue:2

    Topics: Animals; Anthracyclines; Antineoplastic Agents; Disease Models, Animal; Doxorubicin; Extravasation of Diagnostic and Therapeutic Materials; Female; Humans; Mice; Mitoxantrone; Razoxane; Treatment Outcome

2012
Dexrazoxane provided moderate protection in a catecholamine model of severe cardiotoxicity.
    Canadian journal of physiology and pharmacology, 2012, Volume: 90, Issue:4

    Topics: Animals; Calcium; Cardiotonic Agents; Disease Models, Animal; Hemodynamics; Iron; Iron Chelating Agents; Isoproterenol; Male; Myocardial Infarction; Myocardium; Rats; Rats, Wistar; Razoxane

2012
Protective effects of dexrazoxane against acute ischaemia/reperfusion injury of rat hearts.
    Canadian journal of physiology and pharmacology, 2012, Volume: 90, Issue:9

    Topics: Acute Disease; Animals; Arrhythmias, Cardiac; Cardiovascular Agents; Disease Models, Animal; Dose-Response Relationship, Drug; Electrocardiography; In Vitro Techniques; Male; Myocardial Infarction; Myocardial Reperfusion Injury; Perfusion; Rats; Rats, Wistar; Razoxane; Reactive Oxygen Species; Treatment Outcome

2012
Dexrazoxane (ICRF-187) protects cardiac myocytes against hypoxia-reoxygenation damage.
    Cardiovascular toxicology, 2002, Volume: 2, Issue:2

    Topics: Animals; Cardiovascular Agents; Disease Models, Animal; Dose-Response Relationship, Drug; Ethylenediamines; Extracorporeal Membrane Oxygenation; Fluoresceins; Fluorescent Dyes; Glycine; Hypoxia; Ion Transport; L-Lactate Dehydrogenase; Models, Cardiovascular; Myocytes, Cardiac; Rats; Rats, Sprague-Dawley; Razoxane; Time Factors; Treatment Failure

2002
Dexrazoxane's protection of jejunal crypt cells in the jejunum of C3Hf/Kam mice from doxorubicin-induced toxicity.
    Cancer chemotherapy and pharmacology, 2003, Volume: 52, Issue:6

    Topics: Animals; Antibiotics, Antineoplastic; Cell Survival; Disease Models, Animal; Doxorubicin; Idarubicin; Injections, Intraperitoneal; Jejunal Diseases; Jejunum; Male; Mice; Mice, Inbred C3H; Protective Agents; Razoxane

2003
Experimental animal model for anthracycline-induced heart failure.
    European journal of heart failure, 2004, Volume: 6, Issue:4

    Topics: Animals; Anthracyclines; Body Weight; Cardiovascular Agents; Disease Models, Animal; Heart Failure; Heart Rate; Models, Cardiovascular; Razoxane; Stroke Volume

2004
Rabbit model for in vivo study of anthracycline-induced heart failure and for the evaluation of protective agents.
    European journal of heart failure, 2004, Volume: 6, Issue:4

    Topics: Animals; Anthracyclines; Antibiotics, Antineoplastic; Biomarkers; Body Weight; Cardiovascular Agents; Daunorubicin; Disease Models, Animal; Dose-Response Relationship, Drug; Echocardiography; Erythrocyte Indices; Heart Failure; Heart Rate; Heart Ventricles; Male; Models, Cardiovascular; Myocardium; Myocytes, Cardiac; Rabbits; Razoxane; Stroke Volume; Time Factors

2004
Antitumor effects of two bisdioxopiperazines against two experimental lung cancer models in vivo.
    BMC pharmacology, 2004, Dec-24, Volume: 4

    Topics: Animals; Antineoplastic Agents; Carcinoma, Lewis Lung; China; Disease Models, Animal; Drug Therapy, Combination; Female; Humans; Lung Neoplasms; Male; Mice; Mice, Inbred C57BL; Neoplasm Transplantation; Razoxane; Tumor Cells, Cultured; Xenograft Model Antitumor Assays

2004
Myocardial content of selected elements in experimental anthracycline-induced cardiomyopathy in rabbits.
    Biometals : an international journal on the role of metal ions in biology, biochemistry, and medicine, 2005, Volume: 18, Issue:2

    Topics: Animals; Anthracyclines; Antibiotics, Antineoplastic; Calcium; Cardiomyopathies; Disease Models, Animal; Iron; Magnesium; Male; Myocardium; Potassium; Rabbits; Razoxane; Selenium; Trace Elements

2005
Evaluation of ECG time intervals in a rabbit model of anthracycline-induced cardiomyopathy: a useful tool for assessment of cardioprotective agents.
    Physiological research, 2007, Volume: 56, Issue:2

    Topics: Aldehydes; Animals; Cardiomyopathies; Cardiotonic Agents; Chronic Disease; Daunorubicin; Disease Models, Animal; Drug Evaluation, Preclinical; Electrocardiography; Heart Conduction System; Hydrazones; Iron Chelating Agents; Male; Myocardial Contraction; Pyridoxal; Rabbits; Razoxane; Time Factors; Troponin T

2007
Survival analysis of drug combinations using a hazards model with time-dependent covariates.
    Biometrics, 1980, Volume: 36, Issue:3

    Topics: Altretamine; Animals; Antineoplastic Agents; Disease Models, Animal; Drug Therapy, Combination; Female; Leukemia L1210; Mice; Razoxane; Risk

1980
[Myocardial disease caused by adriamycin. Experimental animal models and possible pharmacologic prevention].
    Minerva medica, 1982, May-07, Volume: 73, Issue:19

    Topics: Animals; Cardiomyopathies; Carnitine; Disease Models, Animal; Doxorubicin; Mice; Rabbits; Rats; Razoxane; Verapamil

1982
Combination chemotherapy and surgical adjuvant chemotherapy on MS-2 sarcoma and lung metastases in mice.
    European journal of cancer, 1979, Volume: 15, Issue:5

    Topics: Animals; Antineoplastic Agents; Cyclophosphamide; Disease Models, Animal; Doxorubicin; Drug Therapy, Combination; Lung Neoplasms; Mice; Mice, Inbred BALB C; Neoplasm Transplantation; Razoxane; Sarcoma, Experimental; Time Factors; Transplantation, Isogeneic

1979
A study of the influence of various diagnostic and therapeutic procedures applied to a murine squamous carcinoma on its metastatic behaviour.
    British journal of cancer, 1975, Volume: 32, Issue:3

    Topics: Animals; Biopsy; Carcinoma, Squamous Cell; Disease Models, Animal; Female; Humans; Immunization; Lymph Node Excision; Mice; Mice, Inbred Strains; Neoplasm Metastasis; Neoplasm Transplantation; Neoplasms, Experimental; Razoxane; Transplantation, Isogeneic

1975
Efficacy of bimolane in the Malassezia ovalis model of psoriasis.
    The Journal of dermatology, 1991, Volume: 18, Issue:12

    Topics: Administration, Cutaneous; Administration, Oral; Animals; Betamethasone Valerate; Disease Models, Animal; Female; Injections, Intravenous; Malassezia; Methotrexate; Psoriasis; Rabbits; Razoxane; Skin

1991